Freddy Heitz

Freddy joined Genkyotex in 2008 as Head of Screening and Biotechnology with more than 12 years of pharmaceutical industry experience and a strong knowledge of the drug discovery process.

He is responsible for development of Genkyotex’s unique NOX screening platform. Prior to joining Genkyotex, Freddy was Principal Scientist in the screening department of Siena Biotech (Siena, Italy).

He was responsible for all aspects of assay development and played a leading role in the EU funded STREP project to identify new targets in Huntington’s disease, a rare neurodegenerative disease. He also designed and developed an innovative high throughput screening approach that led to the identification of novel small molecules candidates as disease-modifiers for Huntington’s disease.

Freddy holds a PhD in pharmacology and molecular biology from Louis Pasteur University (Strasbourg).

Freddy Heitz is the Head of Screening and Biotechnology at Genkyotex, based in Switzerland, Europe. With a background in Biotechnology, Freddy Heitz has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.